Artwork

Nội dung được cung cấp bởi Squirro. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được Squirro hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.
Player FM - Ứng dụng Podcast
Chuyển sang chế độ ngoại tuyến với ứng dụng Player FM !

Spotlight Six: The Integration of AI in Life Sciences and Biotechnology Sectors

1:38
 
Chia sẻ
 

Manage episode 408266731 series 3454356
Nội dung được cung cấp bởi Squirro. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được Squirro hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.

Season Three - Spotlight Six

Our sixth spotlight of this season is a snippet from our upcoming episode:⁠ Dave Latshaw, Ph.D., MBA - The Integration of AI in Life Sciences and Biotechnology Sectors.

Join host Lauren Hawker Zafer as she engages in a riveting discussion with Dave Latshaw, Ph.D., MBA a visionary leader renowned for his groundbreaking work at Johnson & Johnson and founding BioPhy.

Together, they unravel the complexities of integrating AI into the life sciences and biotechnology sectors, exploring topics ranging from cost-saving implementations to ethical considerations in drug development.

This episode is a must-listen for entrepreneurs, healthcare professionals, and AI enthusiasts eager to understand the transformative potential and ethical implications of AI in shaping the future of healthcare and drug development.

Who is Dave Latshaw, Ph.D., MBA?

Dave received his Ph.D. in chemical and biomolecular engineering from North Carolina State University and went on to get his MBA at Wharton. He began his career at The Janssen Pharmaceutical Companies of Johnson and Johnson, working in a group that was responsible for overseeing the manufacturing of large molecule antibodies, and was the youngest person ever to lead an AI research group at J&J.

Dave also led flagship programs for the company’s AI Advanced Center of Excellence, and enabled J&J’s billion dose commitment during the COVID pandemic. Before leaving J&J and pursuing his MBA, Dave was inducted into Frontiers of Engineering, an organization created by the National Academy of Engineering to recognize top early-career engineers.

While studying at Wharton, the idea of BioPhy originated and later evolved into a life sciences health tech company in 2020. Dave examines opportunities down to first principles using a blend of business acumen, analytics, and the scientific process to use artificial intelligence and biophysics concepts to bring value to the healthcare value chain.

Listen to the full episode, as soon as it comes out by subscribing to Redefining AI and please do share your excitement about the episode with your own network!

#ai #data #redefiningai #techpodcast #generativeai

  continue reading

87 tập

Artwork
iconChia sẻ
 
Manage episode 408266731 series 3454356
Nội dung được cung cấp bởi Squirro. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được Squirro hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.

Season Three - Spotlight Six

Our sixth spotlight of this season is a snippet from our upcoming episode:⁠ Dave Latshaw, Ph.D., MBA - The Integration of AI in Life Sciences and Biotechnology Sectors.

Join host Lauren Hawker Zafer as she engages in a riveting discussion with Dave Latshaw, Ph.D., MBA a visionary leader renowned for his groundbreaking work at Johnson & Johnson and founding BioPhy.

Together, they unravel the complexities of integrating AI into the life sciences and biotechnology sectors, exploring topics ranging from cost-saving implementations to ethical considerations in drug development.

This episode is a must-listen for entrepreneurs, healthcare professionals, and AI enthusiasts eager to understand the transformative potential and ethical implications of AI in shaping the future of healthcare and drug development.

Who is Dave Latshaw, Ph.D., MBA?

Dave received his Ph.D. in chemical and biomolecular engineering from North Carolina State University and went on to get his MBA at Wharton. He began his career at The Janssen Pharmaceutical Companies of Johnson and Johnson, working in a group that was responsible for overseeing the manufacturing of large molecule antibodies, and was the youngest person ever to lead an AI research group at J&J.

Dave also led flagship programs for the company’s AI Advanced Center of Excellence, and enabled J&J’s billion dose commitment during the COVID pandemic. Before leaving J&J and pursuing his MBA, Dave was inducted into Frontiers of Engineering, an organization created by the National Academy of Engineering to recognize top early-career engineers.

While studying at Wharton, the idea of BioPhy originated and later evolved into a life sciences health tech company in 2020. Dave examines opportunities down to first principles using a blend of business acumen, analytics, and the scientific process to use artificial intelligence and biophysics concepts to bring value to the healthcare value chain.

Listen to the full episode, as soon as it comes out by subscribing to Redefining AI and please do share your excitement about the episode with your own network!

#ai #data #redefiningai #techpodcast #generativeai

  continue reading

87 tập

Tất cả các tập

×
 
Loading …

Chào mừng bạn đến với Player FM!

Player FM đang quét trang web để tìm các podcast chất lượng cao cho bạn thưởng thức ngay bây giờ. Đây là ứng dụng podcast tốt nhất và hoạt động trên Android, iPhone và web. Đăng ký để đồng bộ các theo dõi trên tất cả thiết bị.

 

Hướng dẫn sử dụng nhanh